FDA Drug Shortage Database
Quinapril (Accupril) shortage
The FDA Drug Shortage Database lists 12 of 16 quinapril presentations as limited or unavailable (updated October 2, 2026); the first entry was posted on January 19, 2023. 4 more presentations are on the list as available.
- Generic listed
- In shortage
- Boxed warning
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 5mg tablet | 3 | 1 | 0 |
| 10mg tablet | 3 | 1 | 0 |
| 20mg tablet | 2 | 1 | 0 |
| 40mg tablet | 3 | 1 | 0 |
Which presentations are listed?
Limited or unavailable now (11)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Quinapril Hydrochloride, Tablet, 10 mg (NDC 43547-411-09) | Solco Healthcare US, LLC | Current posted January 19, 2023, updated June 29, 2026 | Unavailable; Shortage of an active ingredient |
| Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90) | Aurobindo Pharma USA | Current posted January 19, 2023, updated October 2, 2026 | Unavailable; Discontinuation of the manufacture of the drug |
| Quinapril Hydrochloride, Tablet, 10 mg (NDC 68180-557-09) | Lupin Pharmaceuticals, Inc. | Current posted January 19, 2023, updated September 1, 2026 | Unavailable; Requirements related to complying with good manufacturing practices |
| Quinapril Hydrochloride, Tablet, 20 mg (NDC 43547-412-09) | Solco Healthcare US, LLC | Current posted January 19, 2023, updated June 29, 2026 | Unavailable; Shortage of an active ingredient |
| Quinapril Hydrochloride, Tablet, 20 mg (NDC 68180-558-09) | Lupin Pharmaceuticals, Inc. | Current posted January 19, 2023, updated September 1, 2026 | Unavailable; Requirements related to complying with good manufacturing practices |
| Quinapril Hydrochloride, Tablet, 40 mg (NDC 43547-413-09) | Solco Healthcare US, LLC | Current posted January 19, 2023, updated June 29, 2026 | Unavailable; Shortage of an active ingredient |
| Quinapril Hydrochloride, Tablet, 40 mg (NDC 65862-620-90) | Aurobindo Pharma USA | Current posted January 19, 2023, updated October 2, 2026 | Unavailable; Discontinuation of the manufacture of the drug |
| Quinapril Hydrochloride, Tablet, 40 mg (NDC 68180-554-09) | Lupin Pharmaceuticals, Inc. | Current posted January 19, 2023, updated September 1, 2026 | Unavailable; Requirements related to complying with good manufacturing practices |
| Quinapril Hydrochloride, Tablet, 5 mg (NDC 43547-410-09) | Solco Healthcare US, LLC | Current posted January 19, 2023, updated June 29, 2026 | Unavailable; Shortage of an active ingredient |
| Quinapril Hydrochloride, Tablet, 5 mg (NDC 65862-617-90) | Aurobindo Pharma USA | Current posted January 19, 2023, updated October 2, 2026 | Unavailable; Discontinuation of the manufacture of the drug |
| Quinapril Hydrochloride, Tablet, 5 mg (NDC 68180-556-09) | Lupin Pharmaceuticals, Inc. | Current posted January 19, 2023, updated September 1, 2026 | Unavailable; Requirements related to complying with good manufacturing practices |
Listed now, available (4)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Quinapril Hydrochloride, Tablet, 10 mg (NDC 62135-485-90) | Chartwell Molecular Holdings LLC | Current posted January 19, 2023, updated October 2, 2026 | Available |
| Quinapril Hydrochloride, Tablet, 20 mg (NDC 62135-486-90) | Chartwell Molecular Holdings LLC | Current posted January 19, 2023, updated October 2, 2026 | Available |
| Quinapril Hydrochloride, Tablet, 40 mg (NDC 62135-487-90) | Chartwell Molecular Holdings LLC | Current posted January 19, 2023, updated October 2, 2026 | Available |
| Quinapril Hydrochloride, Tablet, 5 mg (NDC 62135-484-60) | Chartwell Molecular Holdings LLC | Current posted January 19, 2023, updated October 2, 2026 | Available |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
Are medicines for the same conditions short too?
Medicines whose labels share an indication with this one, and their own shortage status; listed as records, not substitutes.
| Medicine | Shared indication | Shortage | Generic labelers | Pharmacy cost |
|---|---|---|---|---|
| Lisinopril | High blood pressure, Heart failure | No current entry | 36 labelers | $0.0254 per tablet 20 mg tablet |
| Enalapril | High blood pressure, Heart failure | No current entry | 28 labelers | $0.0664 per tablet 10 mg tablet |
| Hydrochlorothiazide and lisinopril | High blood pressure | No current entry | 27 labelers | $0.0293 per tablet 10-12.5 mg tablet |
| Amlodipine and benazepril | High blood pressure | No current entry | 16 labelers | $0.114 per unit 10-20 mg |
| Benazepril | High blood pressure | No current entry | 21 labelers | $0.0789 per tablet 20 mg tablet |
| Ramipril | High blood pressure | No current entry | 17 labelers | $0.0707 per capsule 10 mg capsule |
| Captopril | High blood pressure, Heart failure | No current entry | 13 labelers | $0.228 per tablet 12.5 mg tablet |
| Fosinopril | High blood pressure, Heart failure | No current entry | 7 labelers | $0.154 per tablet 10 mg tablet |
| Benazepril and hydrochlorothiazide | High blood pressure | No current entry | 3 labelers | $0.222 per tablet 20-12.5 mg tablet |
| Trandolapril | High blood pressure | No current entry | 5 labelers | $0.157 per tablet 1 mg tablet |
| Enalapril and hydrochlorothiazide | High blood pressure | No current entry | 2 labelers | $0.209 per tablet 10-25 mg tablet |
| Captopril and hydrochlorothiazide | High blood pressure | No current entry | 1 labeler | n/a |
Source: FDA drug labels, FDA Drug Shortage Database, NDC Directory, CMS NADAC of October 7, 2026 (FDA files October 8, 2026)
What next?
- Every shortage now
- medicines by presentations in shortage